Literature DB >> 15809923

Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supported patient registry.

Peter G Pappas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15809923     DOI： 10.1086/429329

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

Review 1.  Amphotericin B lipid complex in the management of invasive fungal infections in immunocompromised patients.

Authors:  Matteo Bassetti; Franco Aversa; Filippo Ballerini; Fabio Benedetti; Alessandro Busca; Nicola Cascavilla; Ercole Concia; Andrea Tendas; Francesco Di Raimondo; Patrizio Mazza; Anna Maria Nosari; Giuseppe Rossi
Journal:  Clin Drug Investig       Date:  2011-11-01       Impact factor: 2.859

2.  [Caspofungin after solid organ transplantation in Germany: observational study on treatment of invasive fungal infections].

Authors:  C Lichtenstern; J Pratschke; U Schulz; M Schmoeckel; W Knitsch; P Kaskel; K J Krobot; M A Weigand; M Winkler
Journal:  Anaesthesist       Date:  2010-11-12       Impact factor: 1.041

3.  Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate.

Authors:  Ph Chandrasekar
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

4.  Efficacy and safety of micafungin for the treatment of patients with proven or probable invasive aspergillosis: A non-comparative, multicenter, phase IV, open-label study.

Authors:  Yu Ji; Yongping Song; Fang Zhou; Ting Liu; Ming Jiang; Xielan Zhao; Xiaojun Huang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.